431 related articles for article (PubMed ID: 20667622)
1. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity.
Prado C; Gómez J; López P; de Paz B; Gutiérrez C; Suárez A
Immunobiology; 2011 Mar; 216(3):386-92. PubMed ID: 20667622
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
3. Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.
Bonelli M; von Dalwigk K; Savitskaya A; Smolen JS; Scheinecker C
Ann Rheum Dis; 2008 May; 67(5):664-71. PubMed ID: 17728327
[TBL] [Abstract][Full Text] [Related]
4. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
5. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.
Zanzi D; Stefanile R; Santagata S; Iaffaldano L; Iaquinto G; Giardullo N; Lania G; Vigliano I; Vera AR; Ferrara K; Auricchio S; Troncone R; Mazzarella G
Am J Gastroenterol; 2011 Jul; 106(7):1308-17. PubMed ID: 21468011
[TBL] [Abstract][Full Text] [Related]
6. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
Hahn BH; Anderson M; Le E; La Cava A
Arthritis Rheum; 2008 Aug; 58(8):2488-97. PubMed ID: 18668553
[TBL] [Abstract][Full Text] [Related]
7. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
Raghavan S; Cao D; Widhe M; Roth K; Herrath J; Engström M; Roncador G; Banham AH; Trollmo C; Catrina AI; Malmström V
Ann Rheum Dis; 2009 Dec; 68(12):1908-15. PubMed ID: 19066178
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
9. [Study of CD4+ CD25+ regulatory T cells and expression of Foxp3 mRNA in bronchiolitis and glucocorticoid regulation].
Zhu YF; Cai XH; Zhu JY; Jiang WP; Lan JH; Liu S
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(22):1563-6. PubMed ID: 19953886
[TBL] [Abstract][Full Text] [Related]
10. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
11. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
[TBL] [Abstract][Full Text] [Related]
12. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
[TBL] [Abstract][Full Text] [Related]
13. Characterization of CD4+ FOXP3+ T-cell clones established from chronic inflammatory lesions.
Okui T; Ito H; Honda T; Amanuma R; Yoshie H; Yamazaki K
Oral Microbiol Immunol; 2008 Feb; 23(1):49-54. PubMed ID: 18173798
[TBL] [Abstract][Full Text] [Related]
14. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ regulatory T cells in irritable bowel syndrome patients.
Holmén N; Isaksson S; Simrén M; Sjövall H; Ohman L
Neurogastroenterol Motil; 2007 Feb; 19(2):119-25. PubMed ID: 17244166
[TBL] [Abstract][Full Text] [Related]
17. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
[TBL] [Abstract][Full Text] [Related]
18. CD27 expression discriminates between regulatory and non-regulatory cells after expansion of human peripheral blood CD4+ CD25+ cells.
Duggleby RC; Shaw TN; Jarvis LB; Kaur G; Gaston JS
Immunology; 2007 May; 121(1):129-39. PubMed ID: 17425604
[TBL] [Abstract][Full Text] [Related]
19. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
[TBL] [Abstract][Full Text] [Related]
20. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
